Dr. Ana-Maria Copaescu, Assistant Professor in the McGill Department of Medicine, clinician-scientist at the Research Institute of the McGill University Health Centre (The Institute), and member of the Infectious Diseases and Immunity in Global Health (IDIGH) Program, has been awarded the 2024 Fédération des médecins spécialistes du Québec (FMSQ) Research Award. This recognition is in honor of her impactful publication in JAMA Internal Medicine, titled “Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical Trial.”
Dr. Copaescu’s research presents a safer and more efficient approach to penicillin allergy testing. As the lead investigator for the North American sites of the PALACE study, she has contributed significantly to advancing methods for diagnosing penicillin allergies.
Her expertise spans allergy-immunology, with a focus on drug allergies, diagnostic strategies, and managing severe drug reactions. Dr. Copaescu’s international collaborations, including an honorary fellowship at the University of Melbourne and the Centre for Antibiotic Allergy and Research, have further enriched her work and expanded its global impact.
This award highlights Dr. Copaescu’s commitment to advancing healthcare through innovative research that has meaningful implications both locally and globally.
Related Highlights
World-first clinical trial to help millions of people with penicillin allergies
FMSQ Prix d’excellence et de recherche 2024 (on the FMSQ website)
